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Salmon Gill Poxvirus Disease (SGPVD) has emerged as a cause of acute mortality in
Atlantic salmon (Salmo salar L.) presmolts in Norwegian aquaculture. The clinical phase of
the disease is associated with apoptotic cell death in the gill epithelium causing acute
respiratory distress, followed by proliferative changes in the regenerating gill in the period
after the disease outbreak. In an experimental SGPV challenge trial published in 2020,
acute disease was only seen in fish injected with hydrocortisone 24 h prior to infection.
SGPV-mediated mortality in the hydrocortisone-injected group was associated with more
extensive gill pathology and higher SGPV levels compared to the group infected with
SGPV only. In this study based on the same trial, SGPV gene expression and the innate
and adaptive antiviral immune response was monitored in gills and spleen in the presence
and absence of hydrocortisone. Whereas most SGPV genes were induced from day 3
along with the interferon-regulated innate immune response in gills, the putative SGPV
virulence genes of the B22R family were expressed already one day after SGPV exposure,
indicating a potential role as early markers of SGPV infection. In gills of the hydrocortisone-
injected fish infected with SGPV, MX expression was delayed until day 10, and then
expression skyrocketed along with the viral peak, gill pathology and mortality occurring
from day 14. A similar expression pattern was observed for Interferon gamma (IFNg) and
granzyme A (GzmA) in the gills, indicating a role of acute cytotoxic cell activity in SGPVD.
Duplex in situ hybridization demonstrated effects of hydrocortisone on the number and
localization of GzmA-containing cells, and colocalization with SGPV infected cells in the
gill. SGPV was generally not detected in spleen, and gill infection did not induce any
corresponding systemic immune activity in the absence of stress hormone injection.
However, in fish injected with hydrocortisone, IFNg and GzmA gene expression wasorg June 2021 | Volume 12 | Article 6893021
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Frontiers in Immunology | www.frontiersin.induced in spleen in the days prior to acute mortality. These data indicate that suppressed
mucosal immune response in the gills and the late triggered systemic immune response in
the spleen following hormonal stress induction may be the key to the onset of
clinical SGPVD.Keywords: salmon gill poxvirus, Atlantic salmon, antiviral immunity, cytotoxic cell, mucosal immunity, gill disease,
virulence geneINTRODUCTION
The Salmon gill poxvirus (SGPV) can cause salmon gill poxvirus
disease (SGPVD), often associated with acute, high mortalities in
Atlantic salmon (Salmo salar L.) presmolts. This disease was first
observed in 1995 at a Norwegian salmon hatchery (1), but was
not shown to be associated with a virus until 2008, when viral
particles were detected using transmission electron microscopy
by Nylund et al. (2). In 2015 the full SGPV genome sequence was
published by Gjessing et al. (1). SGPV has since then been
detected in several salmon producing countries in Northern
Europe, including Norway, Scotland and the Faroe Islands (3–
5). SGPV have been associated with gill disease in farmed
Atlantic salmon both at the freshwater presmolt stage and at
the grow-out stage in the sea, although often in combination with
multiple coinfecting agents in the sea (2). The most important
clinical feature of SGPVD is its impact on the A. salmon
respiratory system. Apoptotic gill epithelial cells detach during
the acute phase of the infection, destroying large parts of the
respiratory surface of the gills (1, 6). In the regenerating phase,
epithelial cell hyperplasia leads to a thickened and less functional
respiratory surface. Salmon infected with SGPV usually have no
obvious pathology in other organs based on autopsy and
histology (6), apart from accumulation of red blood cells in the
spleen, a finding not yet clearly associated with SGPVD (6, 7).
Poxviruses represent a family of large enveloped DNA viruses
with a double stranded linear genome, and can cause disease in
several animal species, including mammals, birds, reptiles and
fish (1). The virus family divides into two subfamilies;
chordopoxvirus (ChPV) and entomopoxvirus (EnPV) which
have vertebrates and insects as hosts, respectively (8).
Phylogenetic analyses show that SGPV belongs to the family
ChPV (1). SPGV is measured to a size of 360 x 270 x 250 nm (6)
with a genome of more than 240 kb, putatively encoding 210
proteins (1). Many of the SGPV genes are homologous to other
Chordopoxviruses, such as the genes that enable the virus to
replicate and form viral envelopes. On the other hand, SGPV has
several novel genes not found in other Chordopoxviruses, and as
of today the function of these proteins are unknown (1).
One of the most severe human diseases, Smallpox, was caused
by an orthopoxvirus named variola virus (VARV) (9). Smallpox
disease is now eradicated through vaccination, and the initial
“live” vaccine against VARV was the low pathogenic Vaccinia
virus (VACV) (10), now a widely researched and often used
model for other poxviruses. In 2011, Yang et al. published a
genome-wide transcription map of early-, intermediate-, and late
VACV genes (11), where many of the genes show high similarityorg 2to the SGPV genome (12). In SGPV, three genes (SGPV154,
SPGV159 and SGPV162) are homologous to a putative virulence
protein from the Variola virus, called B22R (1), and are here
renamed to SGPV B22R1, B22R2 and B22R3, respectively. The
B22R genes are of particular interest when it comes to viral
pathogenesis and interactions between the virus and the host
immune system (1). Alzhanova et al. have shown that poxviruses
with B22R encoding genes are associated with suppressed T-cell
responses, and this ability to suppress T-cell activity might be
directly related to virulence (13). SGPV B22R1 has about the
same length as the homologues in other poxviruses, while B22R2
and B22R3 are shorter, suggesting that these two genes have been
truncated during the evolution of SGPV, and may have evolved
by duplication events (1).
The mucosal immune system in the gills is characterized by
several humoral and cellular immune mechanisms that interplay to
protect the tissue from infection (14). Upon infection, both local
populations of immune cells, including mucosal “innate” T-cells
and IgT + B cells, as well as immune cells recruited through blood
from specialized immune organs can help eradicate the infection
(15). The host response to SGPV infection is only vaguely
understood, and due to the many virus encoded genes, there are
many putative host interaction mechanisms (1, 16). Like in
mammals, viral infection in Atlantic salmon trigger the interferon
system, leading to the secondary expression of a range of interferon
response genes including myxovirus resistance gene (MX1) and
interferon stimulated gene (ISG15), which are involved in inhibiting
virus replication (17–19). Interferon regulated genes are previously
shown to be strongly induced in gills from salmon in a natural
SGPVD outbreak (7). Type 2 interferons like IFNg are among
others responsible for activating the cellular cytotoxic response in
innate natural killer cells (NK cells) and adaptive CD8 + T cells (20),
and are shown to be induced in SGPV-infected gills (7).
SGPV infection can turn out differently with regards to
clinical manifestation and mortality. In the field, SGPV
infection can vary from subclinical cases with low virus load to
acute infection causing outbreaks with mortality up to 70% in
severe cases (6). In the aquaculture industry, stress is one of the
main factors that makes farmed fish more prone to disease (21).
Chronic stress associated with high cortisol can be harmful to the
fish, as it can have suppressive effects on immune responses to
infection (22). Cortisol is a chronic stress hormone that can
inhibit the immune system by preventing leukocyte migration to
the local infection site and lead to a general reduction in the
circulation of leukocytes and lymphocytes (23).
In a previously published experimental infection trial (24), we
reported that fish exposed to SGPV developed mild gill pathology,June 2021 | Volume 12 | Article 689302
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seen when fish were injected with hydrocortisone prior to infection.
Stress-induced suppression of the immune system was in that
publication suggested as a potential reason for SGPVD
development (24). Here, we explored the expression of SGPV
genes and antiviral response genes in Atlantic salmon gills along
the experimental infection course from the same trial (24), using
RT-qPCR and RNAscope in situ hybridization. We identified
putative SGPV virulence genes expressed early after infection, and
compared immune responses in gills and spleen from infected fish
groups with or without hydrocortisone injection.MATERIALS AND METHODS
Experimental SGPV Challenge Trial and
Sampling
The samples used for analyses in this study originated from a
previously published infection trial of SGPV in Atlantic salmon
(24). Briefly, Atlantic salmon (n=220; average body weight 50 g)
were divided into 4 groups and were allocated into 4 different
tanks (55/each). Fish in two groups were exposed (E) to SGPV by
cohabitating 55 naive fish (average weight 50g) with 10 fresh
killed SGPV-infected fish (average weight 150g, average gill
SGPV Ct level of 21,3) for 24 hours. The SGPV infected dead
fish used for challenge originated from an ongoing hatchery
outbreak in Northern Norway). Fish in the other two groups
were left as uninfected negative controls (C). To study effects of
cortisol stress on salmon susceptibility to SGPV, one exposed
group and one control group had been injected intraperitoneally
with hydrocortisone (Sigma-Aldrich, St. Louis, MO, USA) (H) in
a depot matrix 24 hours prior to virus exposure. Fish in the other
exposed and control groups had received a sham injection (S) of
the depot matrix without hydrocortisone. The experiment lasted
for 28 days, and gills and spleen samples (n=5) were collected
from fish in all experimental groups at 1, 3, 7, 10, 14, 15, 21 and
28 days post exposure (dpe). The same tissue was divided and
stored in RNAlater (Qiagen Inc., Valencia, CA, USA) for qPCR
and RT-qPCR analysis, and in formalin for in situ hybridization.
More detailed information on the trial is given in Table 1 and
Thoen et al., 2020 (24).
RNA Extraction and cDNA Synthesis
Total RNAwas extracted from spleen and gills using RNeasyMini
kit (Qiagen) according to the manufacturer’s protocol, with minorFrontiers in Immunology | www.frontiersin.org 3modifications in the case of gills. Gill tissue (10-20 mg) was lysed
in 500 ml of QIAzol (Qiagen) and homogenized using 5 mm steal
beads with TissueLyser II (Qiagen) at 24.7 Hz for 2 x 5 minutes.
After homogenization 100 ml of chloroform (VWR, Radnor, PA,
USA) was added to each sample followed by centrifugation at 4°C
and 11 300 rpm for 15 minutes. The upper aqueous phase was
transferred to a new tube and mixed with one volume of 70%
ethanol. The rest of the isolation procedure was performed
according to the manufacturer’s protocol. After RNA extraction,
RNase Out (Life technologies, Carlsbad, CA, USA) was added
each sample. Finally, NanoDrop™ 2000 spectrophotometer
(Thermo Scientific, Waltham, MA, USA.) was used to estimate
purity and yield of RNA, and samples were stored at -80°C.
Reverse transcription to synthesize cDNA was performed using 1
µg RNA input in a 20 mL reaction volume, using the QuantiTect
Reverse Transcription kit (Qiagen) with gDNA elimination
following the manufacturer’s instructions. After synthesis, the
cDNA was diluted (1:20) to prepare working stock, using
Nuclease-free free water. The diluted and the original samples
were stored at -20°C until further use.
Gene Expression Analysis
We used RT-qPCR to analyze the expression of SGPV genes in gills
(B22R1, B22R2, B22R3, D12L, A1L, A2L, A7L, A28L, F9L, G1L), and
the Atlantic salmon genesMX1, ISG15 (gills),CD8a,CD4, IFNg and
GzmA (in gills and spleen) in fish collected from the four
experimental groups (C.S, C.H, E.S, and E.H), at 1, 3, 7, 10, 14,
15, 21 and 28 dpe. The A. salmon elongation factor 1a (EF1a) gene
was used as a housekeeping gene. Primer information is given in
Supplementary Table 1. The amplicon length for each RT-qPCR
product was controlled using 2100 Bioanalyzer with DNA 1000 kit
(Agilent Technologies, Santa Clara, CA.USA), shown in
Supplementary Image 1.
The RT-qPCR was performed using CFX384 Touch Real-
Time PCR Detection System (Bio-Rad Laboratories,
Germany). Each sample was analyzed in duplicate, using a
total reaction volume of 10 µL per well (5 ng cDNA, primers at
10 µM, 2 µL nuclease-free water and 5 µL of 2 x SsoAdvanced™
Universal SYBR® Green Supermix (Bio-Rad Laboratories)
master mix). No-template control (H2O) and no reverse
transcriptase control (NRT) were included on each plate as
negative controls.
The following thermocycling conditions were used: initial
denaturation (30 s at 95°C) followed by 40 cycles of
denaturation (15 s at 95°C) and annealing/extension (30 s at
60°C). A melting curve was made by measuring theTABLE 1 | A summary of trial information derived from (24). The trial lasted for 28 days after SGPV infection. Hydrocortisone injection was given 24 hours earlier









Gill SGPV (DNA) Ct level range in trial ND ND Ct 22,4 – 29,6 Ct 17,8 – 30,9
Group mortality (%) at 28 dpe 0% 0% 0% 100%
Mean gill apoptosis score at 14 dpe
(Severity range 0-3)
0 0 0,5 2,5
Plasma cortisol level at 1 dpe 3,7 ng/mL 43,8 ng/mL 3,8 ng/mL 120,2 ng/mLJune 2021 | Volume 12 | Article 689302
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confirm the specificity of the final amplicon in each reaction.
Quantification cycles (Cq) for every reaction was measured
and RT-qPCR data were analyzed using the CFX Manager
software version 3.1.1621.0826 (Bio-Rad Laboratories). All
gene expression values were then normalized to Ef1a values,
resulting in -DCt values (Ct target genes – Ct EF1a). Raw data
for all RT-qPCR runs are given in Supplementary Table 2
(SGPV genes), Supplementary Table 3 (Salmon genes
gill) and Supplementary Table 4 (Salmon genes spleen).
Variation in Ef1a levels in gill and spleen samples is shown
in Supplementary Image 2. Samples with EF1a Ct values > 1,5
Ct difference from sample set mean) were removed from the
data set.
DNA Extraction and qPCR for SGVP
DNA was extracted from gills using QIAcube and QIAamp
DNA mini kit (Qiagen) as described Thoen et al., 2020 (24).
DNA from gills was analyzed using qPCR (probe assay) from
both E.S and E.H group at 1, 3, 7, 10, 14, 15, 21 and 28 dpe, and
the same assay was used to analyze cDNA from spleen from
both E.S and E.H group at 14 dpe. Each sample was analyzed
in duplicate, using a total reaction volume of 10 µl per well (50
ng DNA, primers and probe at 10 µM, MgCl2 at 50 mM, 1,6 µl
nuclease-free water and 5 µl UDG platinum supermix
(Thermo Scient ific)) . The fol lowing thermocycl ing
conditions were used: UDG incubation (2 min at 50°C),
UDG inactivation (15 min at 95°C) followed by 94 °C/15 s,
55 °C/30 s and 72 °C/15 s.
In Situ Hybridization
In the current study, both the single-plex and duplex variants of
RNAscope protocol was used. RNAscope® 2.5 HD Singleplex
Red Chromogenic Reagent Kit (Advanced Cell Diagnostics Inc.
Newark, CA, USA) was used for the detection of SGPV-B22R1
and D13L transcripts in Atlantic salmon gills at early time points
after virus exposure. For this purpose, serial sections from fish
gills in the E.S group at 1 dpe (n=3), positive control at 3 dpe,
plus uninfected negative control were prepared for probe
hybridization as previously described by Thoen et al. (24).
Briefly, the slides were deparaffinized, rehydrated, and
endogenous peroxidase was blocked using hydrogen peroxide.
The sections were then boiled in target retrieval buffer for 15 min
and incubated with protease at 40°C for 15 min. The sections
were hybridized with probes (Supplementary Table 1) targeting
B22R1 and D13L genes of SGPV with the same amount of probe
used for each section. Fast Red chromogenic substrate was used
to visualize the signal.
RNAscope® 2.5 HD Duplex Detection Chromogenic kit
(Advanced Cell Diagnostics) was used for simultaneous
detection of SGPV-D13L and salmon GzmA in Atlantic
salmon gills from all groups at 7 dpe (n(E.S)= 3, n(E.H)= 3, n(C.S)
= 1, n(C.H)= 1) along with one section from the E.S group and the
E.H group at 14 dpe. Spleen sections included were from 14 dpe
(n(E.S)= 3, n(E.H)= 3, n(C.S)= 1, n(C.H)= 1). Slides were prepared
for probe hybridization as in the single-plex assay. AfterFrontiers in Immunology | www.frontiersin.org 4that, probes targeting SGPV-D13L, and Atlantic salmon GzmA
(Supplementary Table 1) were combined and hybridized to the
prepared sections. Amplification (Amp1 - Amp10), and washing
steps were completed according to the manufacturers’ protocol.
Signals were developed using red substrate for GzmA and green
substrate for SGPV (D13L). All slides were counterstained for
30 seconds using Mayer’s hematoxylin (Chemi Teknik, Oslo,
Norway) diluted 1:1 in distilled water, and mounted with
VectaMount (Vector Labs, Burlingame, CA). An overview of
all sections used for both single-plex and duplex-assays are listed
in Supplementary Table 5.
Statistics
The RT-qPCR data were analyzed in Graphpad Prism 8.0.2. Ct
values from A salmon gene expression were normalized to Ct
levels of EF1a, and relative gene expression was calculated using
the 2-DDCt method. Statistically significant differences between
groups at the time points of focus for our analyses, were
calculated using a two-tailed non-parametric Mann-Whitney
test. P-values are given in the figures in question, and between
additional groups in Supplementary Table 6.
Spearman’s rank correlation (Spearman r) was used to
calculate correlation between expression of MX1 and amount
of virus (DNA) in gill tissue.RESULTS
This study is based on a previously published experimental SGPV
infection trial (24). Table 1 summarizes the background data for the
study groups. We here focus on the factors underlying the mortality
difference associated with SGPV- infected groups with or without
hydrocortisone injection (E.S and E.H groups)
Gene Expression of SGPV B22R
Represents an Early Marker for
SGPV Infection
In the previous report on this infection trial (24), replication of
SGPV was analyzed in gills using a qPCR assay targeting the D13L
gene sequence in the SGPV DNA genome (1). The gene expression
pattern of individual SGPV genes had not been studied previously,
and RT-qPCRwas performed to investigate the expression of SGPV
genes that were predicted to belong to early poxviral genes (B22R1,
B22R2, B22R3, D12L), intermediate genes (A1L, A2L), and late
genes (A7L, A28L, F9L, G1L), based on previous reports from
research on the Vaccinia poxvirus (11). Gills from salmon in both
infected groups, E.S, and E.H, were investigated (Figure 1,
Supplementary Table 2). The expression of the selected SGPV
genes followed a similar trend throughout the experimental trial in
both the E.S and E.H groups, although with higher expression in the
E.H. group (e.g. at 14 dpe for the B22R1 gene: Median in the E.H
group: Ct 20,2 +/- 1,4, Median in the E.S group: Ct 26,9 +/- 14,4)
(Figures 1A-C). These group differences are in line with differences
in SGPV levels based on qPCR targeting the genome (24). All three
B22R genes, predicted for early expression, showed higher
expression/lower Ct values at day 1 compared to all other SGPVJune 2021 | Volume 12 | Article 689302
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levels in the E.H. group (Median: B22R1; Ct 31,7 [+/- 8,8], B22R2;
Ct 32,1 [+/- 8,7], B22R3; Ct 30,8 [+/- 10,5]), compared to the E.S.
group (Median: B22R1; Ct 33,4 [+/- 9,7], B22R2; 33,9 [+/- 7,8,
B22R3; Ct - 32,2 [+/- 11,1]).
In situ hybridization using probes targeting SGPV B22R1
and D13L was performed on selected paraffin-embedded gills
from the E.S group at 1dpe (N=3 in each group). As controls,
two selected paraffin-embedded gills from E.S. group at 3 dpe
were also analyzed. Parallel sections from each gill were stained
with the B22R1 probe and the D13L probe, respectively.Frontiers in Immunology | www.frontiersin.org 5Images o f a l l s e c t i ons ana ly zed are inc luded in
Supplementary Image 3. Positive staining were counted in
the whole gill sections from 1 dpe (Figures 2A, B), and
quantified for comparison between B22R1 and D13L staining
(Figure 2C). At 1 day post exposure, epithelial cells appeared
with normal morphology, and significantly more epithelial
cells stained for B22R1 RNA compared to D13L RNA at this
time point (Figures 2D, E and Supplementary Image 3). At 3
dpe, however, staining for both B22R1 and D13L transcripts
were revealed in the same location (Figures 2F, G and
Supplementary Image 3).A B
C D
FIGURE 1 | Expression of SGPV genes predicted as early-, intermediate- and late based on the Vaccinia virus (11). Each dot represents data from one individual
salmon and the solid line represents the median value for each group. Predicted early genes are marked in blue, predicted intermediate genes in green and predicted
late genes in red. (A) Expression of SGPV genes for the E.S group from day 1 to day 28 in the experimental trial. (B) Highlight from day 1 post-exposure for the E.S
group. (C) Expression of SGPV genes for the E.H group from day 1 to day 14 in the experimental trial. (D) Highlight from day 1 post-exposure for the E.H group.
E.S, SGPV-exposed sham injected group; E.H, SGPV-exposed hydrocortisone-injected group.June 2021 | Volume 12 | Article 689302
Amundsen et al. SGPV Infection - Immunity and StressA B C
D E
F G
FIGURE 2 | Singleplex in situ hybridization (RNAscope) showing detection of SGPV B22R1 and D13L transcripts in gills from Atlantic salmon at 1 and 3 days after
exposure to SGPV (dpe). Whole gill serial sections from 1 dpe (n=3) were scanned for staining of B22R1 and D13L RNA, as marked (A, B), revealing significant
differences in detection of SGPV-positive cells (C). Images of the SGPV-exposed sham injected (E.S) group from 1 dpe stained with B22R1 probe (D) and D13L
probe (E). Serial section from the E.S group from 3 dpe stained with B22R1 probe (F) and D13L probe (G).Frontiers in Immunology | www.frontiersin.org June 2021 | Volume 12 | Article 6893026
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in Gills Infected With SGPV
Expression of the IFN regulated innate antiviral genes MX1 and
ISG15 were analyzed by RT-qPCR in gills from fish in all
experimental groups (Figure 3, Supplementary Tables 3 and 6).
The innate antiviral immune response was monitored in gills only
since SGPV were not detected in blood, and only detected at low
levels in spleen and head kidney in some individuals (24).
MX1 expression was induced from 3 dpe in response to SGPV
infection and stayed elevated throughout the experimental period
(Figure 3A). The MX1 transcript level in the E.H group was
significantly lower at day 3 (p = 0.0079) (Figure 3A insert)
compared to the E.S. group, and was not induced until day 10 post
exposure, and then strongly upregulated along with the viral peak. For
both E.H and E.S groups, there is a statistically significant correlationFrontiers in Immunology | www.frontiersin.org 7between the expression of MX1 and load of SGPV based on SGPV
genome detection with qPCR (Figures 3C, D).
Gene expression of ISG15 follow the same trend as MX1 with a
gradual upregulation of the gene for the E.H and E.S groups, up to the
viral peak at 14 dpe (Figure 3B). However, there were no significant
differences in ISG15 levels between the exposed groups prior to day
14. The gene expression in the two control groups remained stably
low throughout the course for both MX1 and ISG15.
Effect of Hydrocortisone on CD4 and CD8
Gene Expression in Gill and Spleen
The T cell marker transcripts CD4 and CD8a were analyzed in gills
and spleen from the entire challenge experiment to assess the local
and systemic regulation of T cells in the two different organs during
the course of SGPV infection (Figure 4, Supplementary Tables 3, 4A B
C D
FIGURE 3 | Gene expression of Mx1 and ISG15 in gills from Atlantic salmon from the experimental trial. Each dot represents data from one individual salmon and
the solid line represents the median value for each group. The significant differences are calculated between the two infected groups. (A) Gene expression of MX1
for all groups from day 1 to day 28 in the experimental trial. (A-insert) Significant differences between gene expression of MX1 in the two infected groups at 3 dpe.
(B) Gene expression of ISG15 for all groups from day 1 to day 28 in the experimental trial. (C) Ct correlation of MX1 and SGPV DNA (D13L) in the E.S group.
(D) Ct correlation of MX1 and SGPV DNA (D13L) in the E.H group. *P < 0.05, **P < 0.01, *** P < 0.001. C.S, Uninfected control sham injected group; C.H,
Uninfected control hydrocortisone-injected group; E.S, SGPV-exposed sham injected group; E.H, SGPV-exposed hydrocortisone-injected group.June 2021 | Volume 12 | Article 689302
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E.H group in both gills and spleen at 14 dpe (Figures 4A, B). The
gene expression of CD4 in gills also appeared suppressed in the
hydrocortisone injected group (Figure 4C). In the spleen, CD4 gene
expression was significantly lower in the E.H group than the E.S
group at 1 dpe, and higher in the E.H group when this group
suffered from disease mortality (24).
Expression of Cytotoxic Immune
Effector Genes
To monitor cytotoxic immune activity, IFNg and GzmA were
analyzed in gills and spleen from all fish in the challenge
experiment (Figure 5, Supplementary Table 6). In the gills, there
was a significantly higher expression of IFNg from 3 dpe onwards in
the E.S group, peaking at 14 dpe (Figure 5A, Supplementary
Table 2). In contrast, IFNg gene expression was not induced in
spleen in the E.S group, but strongly in the E.H group from day 10Frontiers in Immunology | www.frontiersin.org 8onwards (Figures 5B, Supplementary Table 3). Gene expression of
GzmA shows the same trend as IFNg for all groups in both gill
(Figure 5C) and spleen (Figure 5D).
To explore the relation between GzmA expression and SGPV
infected cells in the gills, duplex in situ hybridization was performed
on selected paraffin-embedded gill sections from all groups at 7 dpe,
in addition to 1 section from the E.S and E.H group at 14 dpe.
GzmA positive cells dominated over SGPV infected cells in the E.S
group for both 7 and 14 dpe (Figures 6A, E, Supplementary Image
4). In the E.H group, however, the number of gill epithelial cells
staining positive for SGPVwere dominant compared to the few cells
staining positive for GzmA (Figures 6B, F). In the control groups,
no staining for SGPV were observed, but moderate staining for
GzmA was seen in the C.S group (Figure 6C). In the C.H group,
only a few GzmA positive cells were observed in the entire gill
section (Figure 6D). In some areas, it was possible to visualize
GzmA positive cells next to with SGPV infected cells (Figure 6F).A B
C D
FIGURE 4 | Gene expression of CD8a in gills (A) and spleen (B) and gene expression of CD4 in gills (C) and spleen (D) from the entire SGPV infection trial. Both
median (line) and individual data (dots) are shown from the SGPV-exposed groups. Control groups are only shown with median value. Significant differences are
calculated between the two infected groups, E.S and E.H. *P< 0.05, **P< 0.01. C.S, Uninfected control sham injected group; C.H, Uninfected control
hydrocortisone-injected group; E.S, SGPV-exposed sham injected group; E.H, SGPV-exposed hydrocortisone-injected group.June 2021 | Volume 12 | Article 689302
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of SGPV, whereas a moderate number of cells were stained for
GzmA in the E.H group (Figure 7A, Supplementary Image 5). In
comparison, only a few cells showed positive staining for GzmA in
the E.S group (Figure 7B). In the C.H group, some cells with
positive staining for GzmA were found, whereas no staining for
GzmA were observed in the C.S group (Supplementary Image 5).DISCUSSION
We aimed in this study to explore SGPV gene expression and the
host immune response to infection, to understand the
mechanisms behind the previously reported hydrocortisone-
mediated triggering of SGPV replication, SGPVD onset and
mortality observed in experimental trials [(24), Table 1].Frontiers in Immunology | www.frontiersin.org 9Large DNA viruses like SGPV contain a wide range of genes
involved in host interaction and can be in a complex interplay
with the host immune system (14, 25). We still know next to
nothing about how SGPV interacts with the mucosal immune
system in Atlantic salmon gills, and have to extrapolate from
research on other poxviruses.
Poxvirus replication is cytoplasmatic, and the transcriptional
machinery is encoded by the virus. In vaccinia, the replication is
determined as a three phase cycle of early, intermediate and late
gene expression, controlled by stage specific transcription factors
(26). The early genes are regulated by transcription factors
carried by the infecting virus and expressed prior to genome
replication, encoding proteins essential for replication and host
interaction (26). Intermediate and late genes are generally
expressed during and post-replication, respectively, and encode
most of the structural proteins to form new viral particles. WhenA B
C D
FIGURE 5 | Gene expression of IFNg in gills (A) and spleen (B) and GzmA in gills (C) and spleen (D) from the experimental trial. Each dot represents data from one
individual salmon and the solid line represents the median value for each group. The significant differences for all figures are measured between the two infected
groups. *P<0.05, **P< 0.01. C.S, Uninfected control sham injected group; C.H, Uninfected control hydrocortisone-injected group; E.S, SGPV-exposed sham injected
group; E.H, SGPV-exposed hydrocortisone-injected group.June 2021 | Volume 12 | Article 689302
Amundsen et al. SGPV Infection - Immunity and Stressexploring gene expression data from a range of SGPV genes
predicted as early, intermediate and late based on previous
studies on the Vaccinia virus (11), we found no obvious
differences in expression throughout the experiment for the
infected groups, with the exception of the B22R gene family.
The lack of variation is most likely due to the limited set of pre-
replication samples available from the study. We had previously
based on qPCR data determined the onset of SGPV genomeFrontiers in Immunology | www.frontiersin.org 10replication to day 3 in this infection trial (24), and had only one
sampling point prior to this (day 1).
However, we found that the predicted early genes encoding
three paralogues of B22R (1–3) were higher expressed at day 1
compared to other SGPV genes, and this points to B22R
transcripts as markers of early SGPV subclinical infection.
SGPV replication is shown earlier to be boosted by
hydrocortisone (24), and we also found a trend towards B22R1A B
C D
E F
FIGURE 6 | Duplex in situ hybridization (RNAscope) demonstrating the distribution of SGPV (D13L, blue staining) and salmon GzmA (red staining) in gills from
Atlantic salmon. (A) E.S group at 7 dpe. (B) E.H group at 7 dpe. (C) C.S group at 7 dpe. (D) C.H group at 7 dpe. (E) E.S group from 14 dpe. (F) E.H group at 14
dpe. Arrow show interaction between GzmA expressing cell and SGPV-infected cell.June 2021 | Volume 12 | Article 689302
Amundsen et al. SGPV Infection - Immunity and Stressbeing higher expressed in the E.H group than in the E.S. group,
and a steeper increase in expression of all SGPV genes towards
the onset of mortality 14 dpe in the E.H group. The in situ
hybridization of B22R1 probes compared to D13L probes also
demonstrated that B22R was expressed in significantly more gill
epithelial cells from day 1, whereas D13L expression were much
lower expressed until day 3. Surprisingly, SGPV genes predicted
to be expressed as late genes (A28L and F9L), appeared to be
expressed at low levels day one, in contrast to genes predicted as
intermediate (A1L and A2L). This could indicate that the SGPV
replication cycle is somewhat divergent from VACV replication.
Although we identified the B22R genes as early markers of
subclinical SGPV infection, the limited set of available samples
from this study were not suited to identify other SGPV genes as
early, intermediate or late. Further work to explore the SGPV
replication cycle is needed, and more excessive early sampling
should be considered in future trials. A cell line susceptible for
SGPV infection would make an excellent tool for future study of
the SGPV infection cycle and the function of SGPV encoded host
interacting proteins. Much is unknown about the SGPVFrontiers in Immunology | www.frontiersin.org 11replication cycle, and effects of stress along with other external
factors like temperature, salinity and the gill mucus microbiome
would be valuable to explore. The in situ hybridization of B22R1
compared to D13L transcripts also demonstrates that B22R1 is
expressed in epithelial cells with normal morphology at day 1
after exposure, whereas D13L expression is predominantly
detected in apoptotic, detaching cells from day 3.
The B22R gene encodes a large transmembrane protein, and
its role have been associated with virulence in other poxviruses
(9). Knocking out the B22R homologue in the monkey poxvirus
(MXPV) led to lower viremia and less mortality, and the viruses
lacking the B22R homologue were associated with higher T-cell
activation after infection, suggesting a role of B22R in
suppression of T cell activity (9). B22R was in that study
reported to interfere after the T-cell receptor (TCR) has bound
the antigen presenting MHC, and suggested to inhibit the
signaling pathway downstream of TCR binding. Since B22R is
a transmembrane protein, the T-cells are thought to be inhibited
through cell-cell contact (13). Given this putative immune
suppressive role of B22R paralogues, or at least the full lengthA
B
FIGURE 7 | In situ hybridization (RNAscope) targeting GzmA (stained in red) in spleen from Atlantic salmon at 14 dpe. (A) SGPV-exposed hydrocortisone-injected
(E.H) group. (B) SGPV-exposed sham-injected (E.S) group.June 2021 | Volume 12 | Article 689302
Amundsen et al. SGPV Infection - Immunity and StressB22R1 in SGPV, the expression of this gene may prove to predict
the putative outcome of infection at an early stage.
In an earlier study of the gill transcriptome of salmon
presmolts infected with SGPV during a natural outbreak of
SGPVD (7), we could not observe any obvious recruitment of
T-cells to gills after infection, and observed an early suppression
of transcript markers of innate T-cell recruitment and activity,
including interleukin (IL)-22, the chemokine CCL20 and T-cell
receptor (TCR) Fcg (7, 13). This effect may be due to chronic
stress or to SGPV virulence factors like B22R acting on T cell
recruitment and/or activation (13). In contrast, strong innate
interferon-regulated gene expression was observed in salmon
gills after SGPV infection, including upregulation of Mx1 and
ISG15 (7). This study showed a correlated increase in MX1
expression and SGPV replication for both infected groups, of
which the E.H group showed a steeper increase from 10 dpe, few
days prior to SGPVD mortality. Previous studies have shown
that high cortisol levels can inhibit the innate immune response,
causing a delay inMX1 expression (27), also shown using cortisol
implants in salmonids (27). At 3dpe, MX1 expression was
significantly higher in the E.S group, supporting previous
studies showing cortisol-mediated suppression of MX1
expression. Whether the reduced MX1 expression early in the
E.H. group determines the more dramatic infection and disease
course in this group is unknown. It is also unclear if this is a
direct effect of cortisol, or regulated by SGPV host interacting
factors with higher expression in this group. Interferon
inhibitory factors have been reported for other poxviruses (28),
and also predicted for SGPV (7). It should be noted that direct
inhibitory effects on poxvirus replication have been reported for
ISG15 (29), but so far not for Mx.
Previous studies in fish have shown that cortisol can inhibit the
immune system by down-regulating the number of circulating
leukocytes and lymphocytes, as well as by preventing leukocytes
from migrating to the area of inflammation (23, 30). The results of
this study indicated a similar effect based on gene expression of
GzmA and IFNg in gills and spleen. In the SGPV infected E.S group,
results indicated a recruitment of cytotoxic cells to gills, based on a
significant increase in the cytotoxic T-cell activity markers IFNg
and GzmA. In contrast, hydrocortisone-injected fish from the E.H
group appear to lack the mobilization of cytotoxic cells to the gills in
the early disease phase, and just immediately prior to SGPVD
mortality, immune activity was induced in both gills and spleen,
most likely due to a systemic immune response in the fish. The
lower immune activity at the local site of infection was also seen in
the intestine of A. salmon treated with hydrocortisone prior to
infection with IPNV (30).
Notably, a significant difference in cytotoxic gene expression
in gills was seen already 3 days post exposure. Since this is early
for an adaptive T-cell response, it is a possibility that IFNg and
GzmA production are associated with innate cytotoxic cells, like
NK cells or NKT-cells. NK cells form part of the first-line defense
against virus-infected cells, and have previously been reported to
be inhibited under chronic stress (31). Furthermore, IFNg has
been shown to enhance respiratory activity and nitric oxideFrontiers in Immunology | www.frontiersin.org 12production (32, 33), which suggests that inhibited IFNg
production in the E.H. group may be one of the contributing
factors to the onset of clinical disease.
In spleen, GzmA and IFNg were strongly upregulated after 10
days in the E.H group. No clear upregulation of CD8a was
detected, but the spleen contains many T cells in the normal state
and it cannot be ruled out that the CD8 T cells are involved in the
production of GzmA and IFNg. The upregulation of GzmA and
IFNg in the spleen few days prior to acute SGPV indicate that the
disease is associated with a systemic immune response in
contrast to the controlled local response in the E.S. group. A
direct regulation of granzyme A expression by cortisol have been
reported, with a putative role in immune cell apoptosis in
response to stress (34). However, this would be expected seen
in the early phase after hydrocortisone injection, and is not a
likely mechanism here. This systemic response does not appear
to be triggered by a systemic infection by SGPV, as no virus was
detected in blood or spleen, as seen in the duplex ISH in fig 7 and
reported in Thoen et al., 2020 (24). From previous field
outbreaks, signs of hemophagocytosis in the spleen have been
observed during histopathological examinations (1, 12), which
could be a sign of a systemic response. Taken together, this study
has revealed that gene expression of the putative virulence gene
B22R is a potential early marker of SGPV infection, detectable
already after one day, and that hydrocortisone injection
suppresses antiviral immune responses to SGPV during early
infection. The immune suppression involves local innate and
cytotoxic T-cell associated antiviral immune activity in gills,
leading to induced SGPV replication. Instead, a boost in innate
and cytotoxic immune response occurs both locally in gills and
systemically in the uninfected spleen a few days prior to the onset
of acute SGPVD and mortality. This indicates that mortality may
be caused by a systemic immune response.DATA AVAILABILITY STATEMENT
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